Axios Re:Cap

Russia’s vaccine gamble

Russia announced Tuesday that it has approved a vaccine for COVID-19 and has plans to inoculate health care workers, teachers, and others in the coming months, despite barely starting Phase 3 clinical trials. Axios Re:Cap producer Naomi Shavin digs into the impacts of this announcement on the vaccine race with Derek Lowe, medicinal chemist, author and expert on drug development and the pharmaceutical industry.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app. 

Axios Re:Cap is on hiatus until October 2021.